Stephanie Federico

University of Trieste — Italy

Biochemistry, Genetics and Molecular Biology · Life Sciences

20h-index985citations82works0.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Adenosine and Purinergic Signaling(50), Receptor Mechanisms and Signaling(28), Synthesis and Biological Evaluation(25), Synthesis and Characterization of Heterocyclic Compounds(15), Pharmacological Receptor Mechanisms and Effects(13)

Publications82 total

Adenosine Receptors in Neuroinflammation and Neurodegeneration
Cells·2025· 1 citedOpen Access
Acyclic purine and pyrimidine nucleotide analogs as ecto-5′-nucleotidase (CD73) inhibitors
European Journal of Medicinal Chemistry·2025Open Access
Towards P2X4 Positron Emission Tomography Tracing
Journal of Medicinal Chemistry·2025· 1 citedOpen Access
7-Amino-[1,2,4]triazolo[1,5-a][1,3,5]triazines as CK1δ inhibitors: Exploring substitutions at the 2 and 5-positions
Bioorganic Chemistry·2024· 1 citedOpen Access
Structural Investigations on 2-Amidobenzimidazole Derivatives as New Inhibitors of Protein Kinase CK1 Delta
Pharmaceuticals·2024Open Access
Adenine derivatives as inhibitors of the casein kinase CK1delta enzyme
Medicinal Chemistry Research·2024· 1 citedOpen Access
Gaucher Disease: A Glance from a Medicinal Chemistry Perspective
ChemMedChem·2024· 2 citedOpen Access
Pyrazolo-triazolo-pyrimidine Scaffold as a Molecular Passepartout for the Pan-Recognition of Human Adenosine Receptors
Biomolecules·2023Open Access
[1,2,4]Triazolo[1,5‐<i>c</i>]pyrimidines as Tools to Investigate A<sub>3</sub> Adenosine Receptors in Cancer Cell Lines
ChemMedChem·2023· 2 cited
Front Cover: Are Two Riboses Better Than One? The Case of the Recognition and Activation of Adenosine Receptors (ChemMedChem 14/2023)
ChemMedChem·2023Open Access
Are Two Riboses Better Than One? The Case of the Recognition and Activation of Adenosine Receptors
ChemMedChem·2023· 3 citedOpen Access
Meet the Editorial Board Member
Current Medicinal Chemistry·2023
“Dual Anta-Inhibitors” of the A2A Adenosine Receptor and Casein Kinase CK1delta: Synthesis, Biological Evaluation, and Molecular Modeling Studies
Pharmaceuticals·2023· 13 citedOpen Access
Adenosine Receptor Ligands, Probes, and Functional Conjugates: A 20-Year History of Pyrazolo[4,3-e][1,2,4]Triazolo[1,5-c]Pyrimidines (PTP)
Topics in medicinal chemistry·2023
Riluzole–Rasagiline Hybrids: Toward the Development of Multi-Target-Directed Ligands for Amyotrophic Lateral Sclerosis
ACS Chemical Neuroscience·2022· 14 citedOpen Access
Promising Targets and Strategies to Control Neuroinflammation (Part I)
Current Medicinal Chemistry·2022
Promising Targets and Strategies to Control Neuroinflammation (Part II)
Current Medicinal Chemistry·2022
The Multifaceted Role of GPCRs in Amyotrophic Lateral Sclerosis: A New Therapeutic Perspective?
International Journal of Molecular Sciences·2022· 21 citedOpen Access
Glycogen Synthase Kinase 3β Involvement in Neuroinflammation and Neurodegenerative Diseases
Current Medicinal Chemistry·2022· 44 citedOpen Access
A Computational Workflow for the Identification of Novel Fragments Acting as Inhibitors of the Activity of Protein Kinase CK1δ
International Journal of Molecular Sciences·2021· 20 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Giampiero Spalluto(49), Stefano Moro(33), Karl‐Norbert Klotz(21), Giorgia Pastorin(16), Barbara Cacciari(16), Siew Lee Cheong(10), Silvia Paoletta(10), Sonja Kachler(8), Antonella Ciancetta(7), Kenneth A. Jacobson(7), Gopalakrishnan Venkatesan(6), Stephen Redenti(6), Maicol Bissaro(6), Mattia Sturlese(6), Priyankar Paira(5), Teresa Gianferrara(4), Eleonora Cescon(4), Zhan‐Guo Gao(4), Davide Bassani(4), Matteo Pavan(4)